[HTML][HTML] Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia

A Datta, J Qian, R Chong, RN Kalaria, P Francis… - Journal of …, 2014 - Elsevier
Vascular dementia (VaD) is a leading cause of dementia in the elderly together with
Alzheimer's disease with limited treatment options. Poor understanding of the …

Degenerative protein modifications in the aging vasculature and central nervous system: A problem shared is not always halved

X Gallart-Palau, A Serra, Y Gao, HH Ho… - Ageing research …, 2019 - Elsevier
Aging influences the pathogenesis and progression of several major diseases affecting both
the cardiovascular system (CVS) and central nervous system (CNS). Defining the common …

Pathophysiology, cellular and molecular mechanisms of large and small vessel diseases

J Koueik, UV Wesley, RJ Dempsey - Neurochemistry International, 2023 - Elsevier
Cerebrovascular disease (CVD) is the second most common cause of cognitive impairment
and dementia in aged population. CVD presents in a myriad number of clinical ways based …

Proteomics in stroke research: potentials of the nascent proteomics

A Zhou - Journal of Investigative Medicine, 2016 - journals.sagepub.com
Among omics, the proteomics assumes a unique role in that it offers the effectors or
actuators of a biological condition. This brief review attempts to summarize the development …

The contribution of small vessel disease to neurodegeneration: focus on Alzheimer's disease, Parkinson's disease and multiple sclerosis

F Paolini Paoletti, S Simoni, L Parnetti… - International journal of …, 2021 - mdpi.com
Brain small vessel disease (SVD) refers to a variety of structural and functional changes
affecting small arteries and micro vessels, and manifesting as white matter changes …

Identification of mature atherosclerotic plaque proteome signatures using data-independent acquisition mass spectrometry

N Hansmeier, J Buttigieg, P Kumar… - Journal of proteome …, 2018 - ACS Publications
Atherosclerosis is a chronic inflammatory disease with complex pathobiology and one of the
most common causes of cardiovascular events. The process is characterized by complex …

Proteomic signatures of neuroinflammation in Alzheimer's disease, multiple sclerosis and ischemic stroke

C Thygesen, MR Larsen, B Finsen - Expert Review of Proteomics, 2019 - Taylor & Francis
Introduction: Inflammation is integral in the neuropathology of both chronic and acute
neurological disorders. Knowing the inflammatory profile is important for clarification of …

Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients

M Vervuurt, JM Schrader, AM de Kort, I Kersten… - Acta Neuropathologica …, 2024 - Springer
Cerebral amyloid angiopathy (CAA) is a form of small vessel disease characterised by the
progressive deposition of amyloid β protein in the cerebral vasculature, inducing symptoms …

Proteome profiling of cerebral vessels in Rhesus Macaques: dysregulation of antioxidant activity and extracellular matrix proteins contributes to cerebrovascular aging …

X Wang, Y Liu, Y Jia, H Liu, X Bao, Z He… - Frontiers in Aging …, 2019 - frontiersin.org
Aging is a major risk factor for cerebrovascular disease; however, the molecular
mechanisms of cerebrovascular aging remain to be clarified. The aim of this study was to …

Application of contemporary neuroproteomic techniques in unravelling neurological disorders

M Khurana, SO Rahman, AK Najmi… - Current Protein and …, 2020 - ingentaconnect.com
Decades of research has stunned us with the very distinctive anatomy and physiology of our
brain, and on the other hand, its complexity has always posed great difficulty in treating its …